<DOC>
	<DOCNO>NCT02335593</DOCNO>
	<brief_summary>The purpose study evaluate effect Zinc supplementation health status hemodialysis patient measurement follow Zinc administration : Inflammatory marker , Oxidative stress marker Anemia marker . Also , Evaluation quality life hemodialysis patient Zinc administration use Fatigue severity scale questionnaire .</brief_summary>
	<brief_title>Efficacy Study Zinc Supplementation Anemia , Oxidative Stress Inflammation Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>Under regular hemodialysis least 6 month . Clinically stable condition outpatient . Zincdeficient patient ( plasma Zinc concentration less 80 mcg/dl ) . Patients take antioxidant supplement include vitamin E , Omega3 fatty acid , green tea preparation immunosuppressive medication within 2 month prior enrollment study . Patients receive Al hydroxide phosphate binder . Hospitalization previous month onset trial , active infection . Patients malabsorption disease ( e.g , Crohn 's disease ) , liver disease , cancer , mental retardation , dementia psychiatric illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Hemodialysis patient</keyword>
	<keyword>Zinc</keyword>
	<keyword>Anemia</keyword>
	<keyword>Oxidative stress</keyword>
</DOC>